Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Mar;44(3):300-310.
doi: 10.1007/s00134-018-5088-x. Epub 2018 Feb 26.

Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial

Philippe Montravers  1   2 , Florence Tubach  3 , Thomas Lescot  4 , Benoit Veber  5 , Marina Esposito-Farèse  6 , Philippe Seguin  7 , Catherine Paugam  8 , Alain Lepape  9 , Claude Meistelman  10 , Joel Cousson  11 , Antoine Tesniere  12 , Gaetan Plantefeve  13 , Gilles Blasco  14 , Karim Asehnoune  15 , Samir Jaber  16 , Sigismond Lasocki  17 , Herve Dupont  18 ; DURAPOP Trial Group
Collaborators, Affiliations
Free article
Randomized Controlled Trial

Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial

Philippe Montravers et al. Intensive Care Med. 2018 Mar.
Free article

Abstract

Purpose: Shortening the duration of antibiotic therapy (ABT) is a key measure in antimicrobial stewardship. The optimal duration of ABT for treatment of postoperative intra-abdominal infections (PIAI) in critically ill patients is unknown.

Methods: A multicentre prospective randomised trial conducted in 21 French intensive care units (ICU) between May 2011 and February 2015 compared the efficacy and safety of 8-day versus 15-day antibiotic therapy in critically ill patients with PIAI. Among 410 eligible patients (adequate source control and ABT on day 0), 249 patients were randomly assigned on day 8 to either stop ABT immediately (n = 126) or to continue ABT until day 15 (n = 123). The primary endpoint was the number of antibiotic-free days between randomisation (day 8) and day 28. Secondary outcomes were death, ICU and hospital length of stay, emergence of multidrug-resistant (MDR) bacteria and reoperation rate, with 45-day follow-up.

Results: Patients treated for 8 days had a higher median number of antibiotic-free days than those treated for 15 days (15 [6-20] vs 12 [6-13] days, respectively; P < 0.0001) (Wilcoxon rank difference 4.99 days [95% CI 2.99-6.00; P < 0.0001). Equivalence was established in terms of 45-day mortality (rate difference 0.038, 95% CI - 0.013 to 0.061). Treatments did not differ in terms of ICU and hospital length of stay, emergence of MDR bacteria or reoperation rate, while subsequent drainages between day 8 and day 45 were observed following short-course ABT (P = 0.041).

Conclusion: Short-course antibiotic therapy in critically ill ICU patients with PIAI reduces antibiotic exposure. Continuation of treatment until day 15 is not associated with any clinical benefit. CLINICALTRIALS.

Gov identifier: NCT01311765.

Keywords: Antibiotic therapy; Duration of therapy; Multidrug-resistant bacteria; Peritonitis; Postoperative intra-abdominal infection.

PubMed Disclaimer

Comment in

References

    1. Chirurg. 2016 Jan;87(1):26-33 - PubMed

Publication types

Substances

Associated data